UBS Names Four Top European Financial Stocks, Citing Value and Turnaround Potential

UBS has designated four standout stocks in the European financials sector—ABN AMRO, Allianz, Banco Santander, and Barclays—as its top global equity picks, according to a new report from the investment bank. The selections are based on a framework that assesses macroeconomic conditions, structural industry factors, and individual company fundamentals.

Key Selections and Rationale

UBS analysts highlighted a mix of banking and insurance firms they believe are positioned for strong performance due to strategic shifts, cost controls, and enhanced capital management.

ABN AMRO

The Dutch bank is favored as a turnaround story. After years of lagging peers due to business exits and high compliance costs, UBS notes a new 2028 plan targeting a return on equity above 12% and a cost-income ratio below 55%. Analysts see the stock's valuation, which trades at the lower end of the sector on a price-to-tangible book value basis, as an attractive entry point.

Allianz

Ad

As one of the world's largest insurers, Germany-based Allianz is praised for its strong balance sheet, which provides flexibility for capital returns and growth. UBS argues the company's superior profitability and attractive business mix merit a premium valuation. Allianz recently reported a record first-half operating profit of €9.4 billion, a 9% increase year-over-year.

Banco Santander

The Spanish banking giant is viewed by UBS as one of the best global retail banks for its cost efficiency. The bank is on track to achieve its goal of a return on tangible equity above 20% in 2028. UBS believes the successful integration of its Webster and TSB units could serve as a future catalyst not yet reflected in the bank's current share price.

Barclays

The UK-based bank's diversified model across retail, commercial, and investment banking is a key strength. UBS finds Barclays attractive due to its inexpensive valuation, resilient capital position with a CET1 ratio of 14.3%, and significant potential for capital returns to shareholders.